fbpx
Home Tags Acorda

Tag: Acorda

Acorda drug for Parkinson’s shows positive trial results

The Ardsley biotech company's inhalable form of L-dopa improved motor function in patients with re-emergent symptoms of Parkinson's Disease.

Industry veteran joins Acorda as CFO

Acorda Therapeutics names a biopharma finance expert to guide its business expansion.

Looking for great places to work

What we’re looking for are the best workplaces in Westchester County.

Acorda epilepsy drug tests well

Acorda Therapeutics Inc. reported encouraging results from the first clinical study of a nasal spray to control epileptic seizures.

Generic drugs dent sales, but Acorda ends 2012 ‘strong’

Acorda Therapeutics Inc. reported a 26 percent increase last year in annual revenue from its leading drug brand, though new competing generic pills lowered sales of another of its marketed drugs by about half.

Ardsley biotech company awarded Army contract

Acorda Therapeutics will use an Army contract award for clinical trials of a drug that could treat spinal cord injuries in combat veterans.

Westchester companies again rank among state’s top 50

Two Westchester-based businesses and three companies in the Hudson Valley are ranked among the 50 best companies to work for in New York in 2013.

Acorda seals deal for nasal spray developer

Acorda Therapeutics Inc. in Ardsley has acquired a North Carolina developer of a nasal spray treatment for severe epilepsy.

MS drug sales rise, income drops at Acorda

Acorda Therapeutics Inc. saw a third-quarter rise in sales of its leading drug product, though new competing generic versions have hurt sales of another Acorda drug.

Biotech firm earns marketing honors

Acorda Therapeutics Inc. recently added to its awards for its consumer website and marketing campaign among professionals for its MS drug treatment.

Acorda lawyer to lead international push

Jane Wasman has been named president, international at Acorda Therapeutics Inc. in Ardsley.

Five in county make best companies list

Five Westchester-based companies are rated among the 50 best companies to work for in the state.

Acorda to add to drug pipeline

In a $10-million cash deal, Acorda Therapeutics Inc. in Hawthorne will merge its drug development subsidiary into a privately held pharmaceutical company that is developing a nasal spray treatment for seizures.

Biotech signals rebound in Ardsley

Spurned by one company, the Ardsley Park Science and Technology Center might soon have a new owner and major biotech tenant relocating there.